Biologic agents effective for IBD remission, new meta-analysis reveals

03/30/2011 | Medscape (free registration)

A systematic review found biological therapies for IBD, such as anti-TNF agents and natalizumab, were more effective than a placebo in inducing remission for some patients with active Crohn's disease and ulcerative colitis, according to one analysis published as part of a comprehensive evidence-based review of medical therapies for IBD sponsored by the American College of Gastroenterology and published online March 15. Read the abstract here.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC